Join us at the AACR Annual Meeting 2017, Washington D.C. (April 1–5)

S_5185_NGS_LS_QIAseqUltralow8759_s

In addition to the traditional National Cherry Blossom Festival, this spring Washington, D.C. will welcome the AACR Annual Meeting 2017 on April 1–5!

We’ll be delighted to meet you at our booth (#1643) where you can learn more about our solutions dedicated to cancer research and biomarker discovery, and get acquainted with the new QIAseq miRNA Library Kit. Meet our expert to discuss sample prep, NGS kits and quality control, gene expression and miRNA regulation, pathway analysis and epigenetics, and solid tumor and blood cancer biomarkers.

We’re also hosting a Spotlight Theater presentation and presenting posters. Read below for details!

Spotlight Theater presentation 

Topic: Achieving NGS insights using QIAGEN “Now Generation” technologies

Date/time:  10:00 a.m.,  April 4

Location:  Spotlight Theater A, Exhibit Hall A

Speakers:

Monika Mehta, Ph.D., R&D Scientist, Sequencing Facility, Frederick National Laboratory for Cancer Research (FNLCR), Leidos Biomedical Research, Inc., Advanced Technology Research Facility, Frederick, MD

Brian Dugan, MS, Global Strategic Marketing Manager, Genomics, QIAGEN Sciences, Inc. 6951 Executive Way, Frederick, MD 21073, USA

Space is limited! Register now to reserve your spot. Online registration: click here –> https://go.qiagen.com/AACR2017

 

Poster presentations

Topic 1: Integrative approach to biomarker discovery by performing comparative analysis of two cancers, hepatocellular carcinoma and endometrioid endometrial carcinoma, using genetics and transcriptomics from RNA sequencing data

Date/time:  1:00–5:00 p.m., Monday, April 3

Location: Section 39: 2840 / 13

Authors:  Jean-Noel Billaud, Stuart Tugendreich, Debra Toburen.
QIAGEN Bioinformatics, Redwood City, CA

Read abstract –> http://www.abstractsonline.com/pp8/#!/4292/presentation/3512

 

Topic 2: Evaluation of a new system for collection, stabilization, and purification of circulating tumor DNA

Date/time:  1:00–5:00 p.m., Monday, April 3

Location: Section 30: 2745/15

Authors:  Michael Fleischhacker1, Bernd Schmidt2, Rohan Baker3, Susanne Pedersen3, Natasha Cant4, Maryam Zahedi-Nejad4, Thorsten Voss5, Andrea Ullius5, Daniel Groelz5.
1University of Halle, Germany; 2DRK-Kliniken Berlin-Mitte, Germany; 3Clinical Genomics, North Ryde, Australia; 4QIAGEN Ltd., Manchester, United Kingdom; 5PreAnalytiX GmbH, Hilden, Germany

Read abstract –> http://www.abstractsonline.com/pp8/#!/4292/presentation/1409


Topic 3:
RNA profiles of circulating tumor cells and extracellular vesicles for therapy stratification of metastatic breast cancer patients

Date/time:  8:00 a.m. – 12:00 p.m., Tuesday, April 4

Location: Section 31:  3777 / 3

Authors:  Corinna Keup1, Siegfried Hauch2, Linda Plappert2, Markus Sprenger-Haussels2, Pawel Mach1, Mitra Tewes3, Bahriye Aktas1, Hans-Christian Kolberg4, Rainer Kimmig1, Sabine Kasimir-Bauer1.
1Department of Gynecology and Obstetrics, University Hospital of Essen, Essen, Germany; 2QIAGEN GmbH, Hilden, Germany; 3Department of Internal Medicine (Cancer Research), University Hospital of Essen, Essen, Germany; 4Clinic for Gynecology and Obstetrics, Marienhospital Bottrop gGmbH, Bottrop, Germany

Read abstract –> http://www.abstractsonline.com/pp8/#!/4292/presentation/1381


Topic 4:
RNA fusion detection in thyroid nodules with a targeted RNA sequencing panel

Date/time:  8:00 a.m. – 12:00 p.m., Wednesday, April 5

Location: Section 17: 5408 / 19

Authors:  Song Tian1, Michelle Baird1, Frank Reinecke2, Jixin Deng1, Mohammad Nezami Ranjbar1, Raed Samara1, Eric Lader1
1QIAGEN Sciences Inc., Frederick, MD; 2QIAGEN GmbH, Hilden, Germany

Read abstract –> http://www.abstractsonline.com/pp8/#!/4292/presentation/6761

We look forward to seeing you at the AACR Annual Meeting 2017 in Washington D.C. on April 1–5!

Wei Cao, Ph.D.

Senior Global Marketing Manager, Translational Sciences

Dr. Wei Cao joined QIAGEN in 2010 and currently leads the webinar program, presenting various topics on advanced techniques in biomedical research. She received her Ph.D. from Peking University in China in 2010, and conducted postdoctoral research at Weill Cornell Medical College in New York City. Before joining QIAGEN, Dr. Cao worked as a senior scientist in R&D in pharmaceutical and biotech, focusing on HIV, HCV and cancer drug discovery and development.

Your email address will not be published. Required fields are marked *